(Q73174059)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Radiation dose selection in Hodgkin's disease patients with large mediastinal adenopathy treated with combined modality therapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

J H Elconin

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K B Roberts

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

D A Rizzieri

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Vermont

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R W Clough

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

C Kim

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

R K Dodge

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

L R Prosnitz

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 November 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1097-1105

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

The significance of mediastinal involvement in early stage Hodgkin's disease

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Hodgkin's disease with bulky mediastinal involvement: effective management with combined modality therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Mediastinal tumor size and response to chemotherapy are the only prognostic factors in supradiaphragmatic Hodgkin's disease treated by ABVD plus radiotherapy: ten-year results of the Paris-Ouest-France 81/12 trial, including 262 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Stage IA-IIB Hodgkin's disease: management and outcome of extensive thoracic involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Alternating MOPP and ABVD chemotherapy plus mantle-field radiation therapy in patients with massive mediastinal Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Combined modality therapy for advanced Hodgkin's disease: 15-year follow-up data

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Improved survival in advanced Hodgkin's disease with the use of combined modality therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Combined modality treatment with low-dose radiation and MOPP chemotherapy for children with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Dose-response relationship of complementary radiotherapy following four cycles of combination chemotherapy in intermediate-stage Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Mediastinal irradiation in combined modality therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Radiation following chemotherapy for mediastinal Hodgkin's disease: the outcome of various doses for bulky tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Radiation techniques for the treatment of Hodgkin's disease with combined modality therapy or radiation alone

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Supradiaphragmatic Hodgkin's disease: significance of large mediastinal masses

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

An updated dose-response analysis in Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Hodgkin's disease: a reassessment of prognostic factors following modification of radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Prognostic groups for management of localized Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Theoretical considerations in combinations of localized and systemic therapy for neoplastic disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Low Dose Radiation Therapy and Combination Chemotherapy in the Treatment of Advanced Hodgkin's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Comparison of high-dose and low-dose radiation with and without chemotherapy for children with Hodgkin's disease: an analysis of the experience at the Children's Hospital of Philadelphia and the Hospital of the University of Pennsylvania

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Low-dose radiation therapy and reduced chemotherapy in childhood Hodgkin's disease: the experience of the French Society of Pediatric Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Efficacy and toxicity of multiagent chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Low-dose involved field radiation after chemotherapy in advanced Hodgkin disease. A Southwest Oncology Group randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Mantle irradiation in Hodgkin's disease. An analysis of technique, tumor eradication, and complications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Late effects on pulmonary function of mantle-field irradiation, chemotherapy or combined modality therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Prospective study of long-term pulmonary manifestations of mantle irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Breast cancer and other second neoplasms after childhood Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Second cancers following pediatric Hodgkin's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Incidence of second cancers in patients treated for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Risk of second primary cancers after Hodgkin's disease by type of treatment: analysis of 2846 patients in the British National Lymphoma Investigation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Second solid malignancies after combined modality therapy for Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2800%2900695-7

7 January 2021

10.1016/S0360-3016(00)00695-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11072168%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference